Narjust Florez, Co Director Young Lung Cancer Program at Dana-Farber Cancer Institute, shared on X:
“Dr. Tina Cascone at ESMO26 on the biology of novel immunotherapies.
Bispecific antibodies targeting two immune checkpoints may boost antitumor responses and help overcome resistance.
Exciting science for thoracic oncology.”
Other articles about bispecific antibodies on OncoDaily.
